Therapeutic binding molecules

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12049506
APP PUB NO 20220306754A1
SERIAL NO

17697041

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • Assignment data not available. Check PTO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cariuk, Peter Cambridge, GB 7 0
Huntington, Catherine Cambridge, GB 4 11
Irving, Lorraine Cambridge, GB 7 0
Nys, Josquin Cambridge, GB 2 0
Rees, David Cambridge, GB 25 186
Riley, Aidan Cambridge, GB 3 0
Robinson, Matthew Cambridge, GB 32 354
Schofield, Darren Cambridge, GB 20 14
Thom, Albert Cambridge, GB 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 30, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 30, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 30, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00